Also referred to as skin substitutes, cellular and tissue-based products (CTPs) include non-autologous human skin grafts, non-human skin substitute grafts, and biological products that form a sheet scaffolding. They're increasingly being used in the wound care clinic for the treatment of non-healing wounds including diabetic foot ulcers, pressure ulcers, and venous ulcers. In order to ensure optimal patient care and a smooth insurance reimbursement process, it's important for wound care clinicians to strive for accurate documentation when using CTPs. Christina Le, CNO and Nick Jagodzinski, Atlantic Regional Clinical Coordinator, offer five helpful tips to help you avoid claim denials.
Last week, WCA operational team leaders from around the country met at HQ to discuss and assess performance measures, develop strategic goals, and improve partner performance. The team also discussed ways in which challenges can be addressed by creating effective solutions for continuous improvement.